Trafalgar International (GCAN) Non Operating Income (2018 - 2025)
Greater Cannabis Company (GCAN) posted quarterly Non Operating Income of $1313.0 for Q3 2025, up 122.95% year-over-year from $588.93 in Q3 2024, and up 100.38% quarter-over-quarter from -$342602.0 in Q2 2025.
Trafalgar International (GCAN) Non Operating Income (2018 - 2025) Analysis & Trends
Greater Cannabis Company's Non Operating Income history runs 8 years deep, the most recent figure standing at $1313.0 for Q3 2025.
- In Q3 2025, Non Operating Income rose 122.95% year-over-year to $1313.0; the TTM figure through Dec 2025 stood at -$401264.0 (down 1662.64% YoY), while the FY2025 annual figure was -$1627.0, up 92.85% from the prior year.
- Non Operating Income for Q3 2025 stood at $1313.0, up from -$342602.0 in the prior quarter.
- The five-year high for Non Operating Income was $23510.0 in Q2 2021, with the low at -$342602.0 in Q2 2025.
- The 5-year median for Non Operating Income is -$5722.0 (2024), against an average of -$46283.2.
- Peak annual rise in Non Operating Income reached 122.95% in 2025, while the deepest fall reached 5953.04% in 2025.
- Greater Cannabis Company's Non Operating Income stood at -$76229.0 in 2021, then soared by 93.27% to -$5134.0 in 2022, then jumped by 44.8% to -$2834.0 in 2023, then tumbled by 101.94% to -$5723.0 in 2024, then jumped by 122.94% to $1313.0 in 2025.
- Business Quant data shows GCAN's Non Operating Income at $1313.0 in Q3 2025, -$342602.0 in Q2 2025, and -$59975.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -224.00 Mn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 5.00 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 41.90 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 10.70 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 391,563.00 |
| Sep 30, 2025 | 1,313.00 |
| Jun 30, 2025 | -342,602.00 |
| Mar 31, 2025 | -59,975.00 |
| Dec 31, 2024 | -5,723.00 |
| Sep 30, 2024 | -5,722.00 |
| Jun 30, 2024 | -5,660.00 |
| Mar 31, 2024 | -5,660.00 |
| Dec 31, 2023 | -2,834.00 |
| Sep 30, 2023 | -2,965.00 |
| Jun 30, 2023 | -3,639.00 |
| Mar 31, 2023 | -3,600.00 |
| Dec 31, 2022 | -5,134.00 |
| Sep 30, 2022 | -53,472.00 |
| Jun 30, 2022 | -19,371.00 |
| Mar 31, 2022 | -105,256.00 |
| Dec 31, 2021 | -76,229.00 |
| Sep 30, 2021 | -177,940.00 |
| Jun 30, 2021 | 23,510.00 |
| Mar 31, 2021 | -28,421.00 |